Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-05-03FDA Approved: NITROGLYCERIN — Original Application (Advagen Pharma Ltd)
FDA approved Advagen Pharma Ltd's generic nitroglycerin under an Original Application (ANDA 209779), enabling marketing of the generic produ…
-
FDA approval · 2021-04-08FDA Approved: NICARDIPINE HYDROCHLORIDE — Original Application (Eugia US LLC)
FDA approved Eugia US LLC's original ANDA for nicardipine hydrochloride as a generic product, enabling marketing of the generic once authori…
-
FDA approval · 2021-03-22FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (GLENMARK PHARMACEUTICALS INC., USA)
FDA approves Glenmark's diltiazem hydrochloride as an original ANDA; the product is a generic calcium channel blocker indicated for hyperten…
-
FDA approval · 2021-03-02FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Verapamil Hydrochloride by Mylan Pharmaceuticals, signaling approval of an updated or additional…
-
FDA approval · 2020-11-30FDA Approved: RANOLAZINE — Original Application (Ascend Laboratories, LLC)
FDA approved the original ANDA for ranolazine (generic) from Ascend Laboratories, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-11-18FDA Approved: NIFEDIPINE — Original Application (Elite Pharmaceutical Solution, Inc.)
FDA approved the Original Application for nifedipine from Elite Pharmaceutical Solution, Inc., approving the generic nifedipine product.
-
FDA approval · 2020-11-06FDA Approved: METOPROLOL SUCCINATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved a generic version of metoprolol succinate (Camber Pharmaceuticals) under an Original Application (ANDA 205541).
-
FDA approval · 2020-10-15FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)
The FDA approved the original application for Verapamil hydrochloride from Sagent Pharmaceuticals, establishing a generic version of this ca…
-
FDA approval · 2020-10-15FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original application for Verapamil hydrochloride from Zydus Pharmaceuticals USA Inc., confirming the generic formulation of…
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention [Phase 4]
A Phase 4 clinical trial comparing loading strategies with antiplatelet drugs in patients undergoing elective coronary intervention was term…
-
FDA approval · 2020-07-06FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Eugia US LLC)
FDA approves Verapamil hydrochloride as an original application generic; the product is used to treat hypertension, angina, and certain arrh…
-
FDA approval · 2020-05-14FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Somerset Therapeutics, LLC)
FDA approved a supplemental application for verapamil hydrochloride, a generic version, filed by Somerset Therapeutics, LLC.
-
FDA approval · 2020-05-12FDA Approved: ISOSORBIDE DINITRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Isosorbide Dinitrate from Hikma Pharmaceuticals USA Inc., marking an approved modification t…
-
FDA approval · 2020-04-29FDA Approved: RANOLAZINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for Ranolazine (ANDA 211707), approving a generic Ranolazine pro…
-
FDA approval · 2020-04-29FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for diltiazem hydrochloride (generic) under ANDA074185.
-
FDA approval · 2020-04-28FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare's diltiazem hydrochloride as an original generic application (ANDA) for the established indications of diltia…
-
CLINICAL_TRIALS trial_result · 2020-04-10Clinical Trial Update: Clinical Study of Medicinal Product Cardionat® Using in Health Athlete Volunteers [Phase 4]
Phase 4 clinical trial update for Cardionat® in health athlete volunteers; study completed.
-
FDA approval · 2020-03-31FDA Approved: METOPROLOL SUCCINATE — Original Application (Nivagen Pharmaceuticals, Inc.)
FDA approved an original ANDA for metoprolol succinate, a generic product manufactured by Nivagen Pharmaceuticals, Inc.
-
FDA approval · 2020-03-27FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
FDA approved a supplemental application for verapamil hydrochloride from Nivagen Pharmaceuticals, Inc., updating regulatory status for this …
-
FDA approval · 2020-03-25FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Caplin Steriles Limited)
FDA approves Caplin Steriles Limited's Verapamil Hydrochloride under an Original Application (ANDA). This confirms the availability of a gen…
-
FDA approval · 2020-02-27FDA Approved: RANOLAZINE — Original Application (Micro Labs Limited)
FDA approved the original application for ranolazine from Micro Labs Limited, enabling generic access to this antianginal medication.
-
FDA approval · 2020-02-20FDA Approved: ISOSORBIDE DINITRATE — Supplemental Application (Sandoz Inc.)
The FDA approved a supplemental application for Isosorbide Dinitrate from Sandoz Inc., indicating regulatory approval of a change to the pro…
-
FDA approval · 2020-02-20FDA Approved: ISOSORBIDE DINITRATE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for Sandoz Inc. to update/expand the approval of the generic isosorbide dinitrate.
-
FDA approval · 2020-02-12FDA Approved: RANOLAZINE — Original Application (Lifestar Pharma LLC)
FDA approved the original ANDA for Ranolazine from Lifestar Pharma LLC, authorizing a generic version of the anti-anginal medication.
-
FDA approval · 2020-01-24FDA Approved: RANOLAZINE — Supplemental Application (Radha Pharmaceuticals, Inc)
The FDA approved a supplemental application for Ranolazine from Radha Pharmaceuticals, Inc. This is a modification to the previously approve…